Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease

Background: Hepatocellular carcinoma (HCC) occurs in the majority of patients with underlying chronic liver disease (CLD) of viral and non-viral etiologies, which requires screening for early HCC diagnosis. Liquid biopsy holds great promise now for early detection, prognosis, and assessment of respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sonu, Nadda, Neeti, Paul, Shashi, Gamanagatti, Shivanand, Dash, Nihar Ranjan, Vanamail, Perumal, Saraya, Anoop, Shalimar, Nayak, Baibaswata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723134/
https://www.ncbi.nlm.nih.gov/pubmed/36483538
http://dx.doi.org/10.3389/fmolb.2022.1024193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723134/
https://www.ncbi.nlm.nih.gov/pubmed/36483538
http://dx.doi.org/10.3389/fmolb.2022.1024193

Ejemplares similares